# Advanced Biomed Inc. (ADVB)

Source: https://www.quantisnow.com/company/ADVB
Generated: 2026-11-09T12:41:27.517Z

- Ticker: ADVB
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2025
- SEC CIK: 0001941029

## Latest ADVB news and filings

- 2026-10-13 20:16 UTC [SEC Form 10-K] [SEC Form 10-K filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-advanced-biomed-inc-6745133)
- 2026-09-28 20:30 UTC [SEC Form NT 10-K filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-advanced-biomed-inc-6727874)
- 2026-08-20 17:00 UTC [SEC Form 4] [Large owner Pau Hung To disposed of $84,588,000,000 worth of Common Stock par vlaue $0.001 (176,225 units at $480,000.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-pau-hung-to-disposed-of-84588000000-worth-of-6689827)
- 2026-07-20 21:00 UTC [SEC Form RW filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-advanced-biomed-inc-6642695)
- 2026-07-17 21:00 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-termination-of-a-6641325)
- 2026-07-01 20:30 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-submission-of-matters-6623165)
- 2026-06-30 20:34 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-entry-into-a-6621051)
- 2026-06-04 11:30 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-advanced-biomed-inc-6588543)
- 2026-05-15 13:28 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-advanced-biomed-inc-6556162)
- 2026-05-01 21:15 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-completion-of-acquisition-6527443)
- 2026-04-14 20:30 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-entry-into-a-6499740)
- 2026-04-03 21:15 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-entry-into-a-6488133)
- 2026-03-30 21:32 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-leadership-update-6476808)
- 2026-03-16 20:30 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-other-events-6449772)
- 2026-02-26 21:31 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-material-modification-to-6416593)
- 2026-02-18 12:00 UTC [Advanced Biomed Inc. Announces 1 for 20 Share Consolidation](https://www.quantisnow.com/insight/advanced-biomed-inc-announces-1-for-20-share-consolidation-6398113)
- 2026-02-13 21:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-advanced-biomed-inc-6392797)
- 2026-02-13 13:00 UTC [Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery](https://www.quantisnow.com/insight/advanced-biomed-inc-announces-120case-feasibility-study-with-chimei-medical-6391110)
- 2026-02-10 21:00 UTC [SEC Form 8-K] [Amendment: Advanced Biomed Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/amendment-advanced-biomed-inc-filed-sec-form-8-k-unregistered-sales-6383909)
- 2026-02-02 21:30 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-entry-into-a-6370222)
- 2026-01-27 21:30 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-entry-into-a-6362507)
- 2026-01-23 21:00 UTC [SEC Form DEF 14C filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-def-14c-filed-by-advanced-biomed-inc-6359069)
- 2026-01-21 22:00 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-notice-of-delisting-6356533)
- 2026-01-12 21:00 UTC [SEC Form PRE 14C filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-pre-14c-filed-by-advanced-biomed-inc-6346278)
- 2025-12-30 21:00 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-entry-into-a-6329782)
- 2025-12-30 15:17 UTC [Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary](https://www.quantisnow.com/insight/advanced-biomed-inc-announces-disposal-of-its-hong-kong-subsidiary-6329570)
- 2025-11-19 21:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-advanced-biomed-inc-6286806)
- 2025-11-14 21:00 UTC [SEC Form NT 10-Q filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-advanced-biomed-inc-6280186)
- 2025-10-08 21:00 UTC [SEC Form 10-K] [SEC Form 10-K filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-advanced-biomed-inc-6227870)
- 2025-09-30 20:00 UTC [SEC Form NT 10-K filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-advanced-biomed-inc-6215947)
- 2025-09-19 20:30 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-regulation-fd-disclosure-6206894)
- 2025-09-19 12:30 UTC [Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery](https://www.quantisnow.com/insight/advanced-biomed-inc-announces-launch-of-aperfusc-integrated-perfusion-3d-6206384)
- 2025-07-24 20:00 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-notice-of-delisting-6131426)
- 2025-07-23 21:31 UTC [SEC Form S-1] [SEC Form S-1 filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-advanced-biomed-inc-6130223)
- 2025-06-06 21:20 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-entry-into-a-6076943)
- 2025-05-28 20:00 UTC [SEC Form 8-K] [Advanced Biomed Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/advanced-biomed-inc-filed-sec-form-8-k-leadership-update-6061064)
- 2025-05-15 20:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-advanced-biomed-inc-6041908)
- 2025-04-15 20:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Advanced Biomed Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-advanced-biomed-inc-5988370)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ADVB
- Earnings history: https://www.quantisnow.com/earnings/ADVB
- Dividend history: https://www.quantisnow.com/dividends/ADVB
- Insider transactions: https://www.quantisnow.com/insiders/ADVB
- Options chain: https://www.quantisnow.com/options/ADVB
- SEC 8-K filings only: https://www.quantisnow.com/company/ADVB/8-k
- RSS and alerts for ADVB: https://www.quantisnow.com/docs/rss-feeds.md